REPL · Categories · Upgrades
REPL - Analyst upgrades
Replimune Group Inc. (REPL) analyst upgrades - real-time wire coverage filtered to Upgrades only.
Recent Upgrades for REPL
- Replimune upgraded by Wedbush with a new price targetWedbush upgraded Replimune from Neutral to Outperform and set a new price target of $12.00
- Replimune upgraded by Leerink Partners with a new price targetLeerink Partners upgraded Replimune from Market Perform to Outperform and set a new price target of $17.00
- Replimune upgraded by Cantor FitzgeraldCantor Fitzgerald upgraded Replimune from Neutral to Overweight
- Replimune upgraded by Wedbush with a new price targetWedbush upgraded Replimune from Neutral to Outperform and set a new price target of $12.00
- Replimune upgraded by BMO Capital Markets with a new price targetBMO Capital Markets upgraded Replimune from Underperform to Outperform and set a new price target of $16.00
- Replimune upgraded by Analyst with a new price targetAnalyst upgraded Replimune from Neutral to Overweight and set a new price target of $17.00
- Replimune upgraded by Analyst with a new price targetAnalyst upgraded Replimune from Underweight to Neutral and set a new price target of $8.00
- Replimune upgraded by BMO Capital Markets with a new price targetBMO Capital Markets upgraded Replimune from Underperform to Market Perform and set a new price target of $11.00
- Replimune upgraded by H.C. Wainwright with a new price targetH.C. Wainwright upgraded Replimune from Neutral to Buy and set a new price target of $12.00
- Replimune upgraded by Piper Sandler with a new price targetPiper Sandler upgraded Replimune from Neutral to Overweight and set a new price target of $13.00
- Replimune upgraded by AnalystAnalyst upgraded Replimune from Underweight to Neutral
- Replimune upgraded by Leerink Partners with a new price targetLeerink Partners upgraded Replimune from Market Perform to Outperform and set a new price target of $13.00
- Replimune upgraded by Wedbush with a new price targetWedbush upgraded Replimune from Neutral to Outperform and set a new price target of $18.00
- Replimune upgraded by Cantor FitzgeraldCantor Fitzgerald upgraded Replimune from Neutral to Overweight